Phase I/Investigational Therapeutics Program
The Phase I/Investigational Therapeutics Program is a multidisciplinary scientific focus group designed to develop new methods for the treatment of cancer. The program includes a team of medical oncologists, nurses, research scientists, data coordinators and social workers who have extensive experience in providing novel therapeutic strategies. Through this program, patients and physicians have access to the newest and most promising anti-cancer treatments supported by both the National Cancer Institute and pharmaceutical companies. Patients with a variety of malignancies are typically eligible to receive these treatments. The team meets weekly to discuss current and pending clinical trials and reviews all patients on Phase I clinical trials. View available Phase I cancer clinical trials.
Staff of this Program: |
Pediatric Hematology/Oncology Program
Adult Oncology Program
Breast Oncology - Stacy Goldstein Breast Cancer Center Gastrointestinal/Hepatobiliary Oncology Program Genetic Counseling and Risk Assessment/The LIFE Center Leukemia/Lymphoma/Hematologic Malignancies Liver Cancer and Bile Duct Cancer Care Program Melanoma and Soft Tissue Oncology Program Phase I/Investigational Therapeutics Prostate Cancer: Dean and Betty Gallo Prostate Cancer Center Stem Cell Transplantation Program
|
